SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | n/a |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 138,540.00 |
| Book Value / Share | n/a |
| Price / Book | n/a |
| NCAV ($M) | -176,227.00 |
| NCAV / Share | n/a |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.39 |
| Return on Assets (ROA) | 0.35 |
| Return on Equity (ROE) | 1.06 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.56 |
| Current Ratio | 0.74 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 174,395.00 |
| Assets | 489,162.00 |
| Liabilities | 350,622.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 290,403.00 |
| Operating Income | 134,039.00 |
| Net Income | 100,988.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 120,968.00 |
| Cash from Investing | -128,895.00 |
| Cash from Financing | 8,735.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,454,008 | 10,137,667 | 24.21 | |
| 2,235,054 | 11,060,951 | 20.21 | |
| 2,683,000 | 12,042,499 | 22.28 | |
| 1,957,182 | 9,503,193 | 20.59 | |
| 1,366,868 | 8,037,597 | 17.01 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABBV – AbbVie Inc. | ABT – Abbott Laboratories |
| ADCT – ADC Therapeutics SA | ANRO – Alto Neuroscience, Inc. |
| ANVS – Annovis Bio, Inc. |
Financial data and stock pages provided by
Fintel.io